Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)

Exclusion Criteria

• •You will not be eligible for this study if you:
• •Have received more than 4 weeks of treatment with nucleoside anti-HIV medications (NRTIs), or more than 1 week with protease inhibitors. (All anti-HIV treatments other than study medications must be stopped at least 14 days prior to study entry.)
• •Have severe diarrhea.
• •Are pregnant or breast-feeding.
• •Have a history of pancreatic disease or any other serious condition.
• •Have hepatitis within 30 days prior to study entry.
• •Cannot take medications by mouth.
• •Have received certain medications.